Regeneron (NASDAQ: REGN) is a leading science and technology company delivering life-transforming medicines for serious diseases.

Our goal is to address serious medical conditions, across multiple and diverse therapeutic areas. Our FDA-approved medicines are only the beginning of our long-term commitment to solve the human body's most complex mysteries.

To achieve our mission to repeatedly bring important new medicines to patients with serious diseases, we remain committed to running our business responsibly and operating with the highest standards of integrity. This commitment underscores our philosophy of ‘doing well by doing good,’ every day.